Therapeutic potentials of human microfluidic encapsulated conjunctival mesenchymal stem cells on the rat model of Parkinson's disease
CONCLUSION: It can be concluded that CJ-MSCs therapy can have protective effects against PD complications and nerve induction of cells due to their ability to express dopamine. On the other hand, CJ-MSCs microencapsulating leads to enhance even more protective effect of CJ-MSCs. However, confirmation of this hypothesis requires further studies and investigation of these cells' possible mechanisms of action.PMID:34619140 | DOI:10.1016/j.yexmp.2021.104703
Source: Experimental and Molecular Pathology - Category: Pathology Authors: Meysam Forouzandeh Mohammadreza Bigdeli Hossein Mostafavi Samad Nadri Mehdi Eskandari Source Type: research
More News: Brain | Neurology | Parkinson's Disease | Pathology | Stem Cell Therapy | Stem Cells | Study | Transplants